Delivery Order SPE2DB22D2211-SPE2DB24FNTL8

Award Date 6/17/24
Potential Completion Date 6/18/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,138.58, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION, a specialty pharmaceutical product, with a ceiling value of $2,438.23 and a performance period through January 17, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML. The contract has a firm fixed price of $4,732.36 and a completion date of August 20, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999, that enables the government to efficiently procure a comprehensive...
This is a $1,526.84 firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The order is for CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical products and medical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML. The contract has a ceiling value of $1,691.31 and a period of performance through August 7, 2024. It is a firm fixed price contract, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, valued up to...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML. The contract has a ceiling value of $2,555.51 and is a Firm Fixed Price Delivery Order. The award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen Drug Corp holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. This IDC...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product, with a ceiling value of $3,784.91 and a completion date of February 7, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML. The contract is a Firm Fixed Price agreement with a ceiling value of $1,295.74 and a completion date of November 18, 2024. The award is not designated as a set-aside contract. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,298.60, is for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of November 25, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CIPROFLOX-DEXAMETH OTIC SUSP 7.5ML, a pharmaceutical product. The contract has a total ceiling value of $1,894.56 and an ultimate completion date of October 8, 2024. It is a firm-fixed-price contract, without any set-aside designation. Amerisourcebergen, a major pharmaceutical distributor, will be the prime contractor responsible for delivering the required medical...
  • SPE2DB22D2211
    Indefinite Delivery Contract
  • SPE2DB22D2211-SPE2DB24FNTL8
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of CIPROFLOX-DEXAMETH OTIC SUSPENSION 7.5ML. The award has a Firm Fixed Price contract type and a ceiling value of $1,552.08. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 5/17/25, 9:58 AM